Northwestern Medicine investigators have discovered a potential multi-faceted therapeutic target for preventing and treating the metabolic syndrome, according to a recent study.
Browsing: Clinical Breakthroughs
Northwestern Medicine investigators have identified a potential combined targeted therapy approach for treating glioblastoma, according to a recent study published in the journal Scientific Reports.
Feinberg investigators continue to investigate new treatments for COVID-19 and share insights on combating misinformation and mitigating the disease’s spread.
A drug that demonstrated neuroprotective effect and slowed disease progression in animal models of Parkinson’s disease showed no symptomatic benefit in patients with the neurodegenerative disorder, according to results from a clinical trial led by Northwestern Medicine investigators.
An experimental drug called ezogabine reduced spinal neuron excitability in patients with ALS, according to a recent study.
A multi-disciplinary team of investigators led by Northwestern scientists have developed a novel wireless device that can constantly monitor pressure and temperature between the patient’s skin and prosthesis, improving overall comfort and wellbeing.
Vitrectomy surgery and intravitreal injections showed similar effectiveness in improving overall vision for patients with advanced diabetic retinopathy, according to results from a clinical trial published in JAMA.
A new study has found many physicians report being sexually harassed and personally attacked on social media on the basis of their religion, race or medical recommendations.
Northwestern Medicine investigators have shown how COVID-19 pneumonia is different from typical cases of pneumonia, spreading across the lungs like multiple wildfires and leaving tissue damage in its wake.
Certificate of need laws — regulations intended to control hospital capacity expansion and improve quality of care — may not be having their intended effects, according to a Northwestern Medicine study.